poisons unit or the use of the National Poisons Information Service database (Toxbase). Only five of the centres recommended the administration of N-acetylcysteine up to 24 hours after paracetamol ingestion.
A treatment line was available in 20 of the 24 departments, with no graph displayed in the other four departments. There was considerably variation in the source of the treatment graphs employed, as shown in table 2. Only four of the departments indicated that they would lower the threshold for treatment in patients at particular risk of liver damage.
1995: AFTER CIRCULATION OF NATIONAL GUIDELINES
All 24 departments responded. Twenty three of 24 departments now had formal written policies regarding the management of paracetamol toxicity, and 20 used national guidelines. Three of these 20 departments supplemented the national guidelines with in house policies. Three departments relied on in house policies alone. In two of these, differences from national treatment recommendations were minimal, and the issue of treatment up to 24 hours after ingestion was adequately addressed. In the third department it was not clear from the protocol used whether they would give antidote beyond 16 hours postingestion unless the patients' INR (international normalised ratio) values were above 2.
The single department without a formal written policy employed a copy of data extracted from Toxbase two years previously, which did not at the time recommend antidotal treatment beyond 15 hours. Thus overall, 22 of the 24 departments definitely recommended the administration of N-acetylcysteine up to 24 hours after paracetamol ingestion.
A treatment nomogram was available to staff in all 24 departments (table 3) . In 20, this was in the form of the nationally accepted document or a wall chart. Four of these 20 departments also displayed an in house graph. Four departments relied solely on in house graphs. One adequately mirrored the formal nomogram, while three failed to recommend treatment beyond 16 hours postingestion (one contradicting its own written guidelines), with one of these also showing inaccuracies regarding the treatment threshold for patients at special risk of liver damage.
Thus overall all 24 departments have taken account of the effect of high risk situations on treatment threshold, though duplication of information and inconsistencies between policy documents and treatment nomograms could lead to confusion over threshold modifications and timing of treatment in up to seven of the 24 departments.
Discussion
The impact of formal treatment guidelines is evident from the improvement seen in the availability of management policies and treatment nomograms to the staff working in this sample group of A&E departments. Most now have access to accurate information on the use of antidotal treatment up to 24 hours after paracetamol ingestion and the threshold modifications for circumstances associated with high risk of liver damage. Confusion could, however, arise where in house modifications of policies and nomograms contradict formal documents, or where in house material is used to supplement national guidelines. Although there were no important differences in content between the national and regional guidelines mentioned earlier, the display of more than one of these in a particular department could lead to confusion. At this time there seems little justification for the use of in house guidelines unless they accurately represent the expert opinion on which the national guidelines are based.
A revised wall chart incorporating a treatment nomogram (fig 1) was distributed in June 1995. This takes into account evidence concerning the increased risk of liver damage in patients with conditions causing depletion of glutathione, such as starvation and HIV infection7-' and in staggered paracetamol overdose.'0 Also considered are changes in the recommendations regarding the timing of gastric emptying and administration of activated charcoal, together with an outline of the management of paracetamol poisoning in children. The information contained in the wall chart is reproduced in the appendix. We would recommend that this information, which could be updated at regular intervals, should form the basis for treatment guidelines for the management of paracetamol poisoning in A&E departments throughout the United Kingdom. Finally, although research in clinical toxicology is often difficult and heavily reliant on case reports, evidence based guidelines can be developed from the available research and can help to inform clinicians about best practice. The applicability of this approach to other areas within clinical toxicology should be explored.
We thank the directors of the National Poisons Information Service (NPIS) centres for producing the revised guidelines and the British Association for Accident and Emergency Medicine for their advice, comments, and help in distribution. The King's Liver Unit also provided valuable advice in formulating the guidelines and the Paracetamol Information Centre funded the study. 6 The threshold for treatment of paracetamol overdose with antidotes should be reduced for patients whose liver microsomal oxidases may be induced. We suggest that the plasma paracetamol concentration for treatment at any time after ingestion be 50% of that recommended for non-induced patients. Line B (graph) is therefore the proposed treatment line for induced patients. 7 The British National Formulary, No 29 (1995) recommends the following dose requirements:
Acetylcysteine. Dose: by intravenous infusion, in glucose intravenous infusion 5%, initially 150 mg/kg in 200 ml over 15 min, followed by 50 mg/kg in 500 ml over 4 h, then 100 mg/kg in 1000 ml over 16 h. Methionine. Dose: by mouth, 2.5 g initially, followed by three further doses of 2.5 g every 4 h.
STAGGERED OVERDOSES
In patients who have taken staggered overdoses, blood levels are meaningless in relation to the treatment graph. These patients should all be considered for treatment with NAC and be discharged only if international normalised ratio (INR) and creatinine are normal.
MANAGEMENT OF PATIENTS WHO PRESENT WITHIN 8 H OF INGESTION
1 Consider emptying the stomach or giving activated charcoal if it is thought that more than 150 mg/kg body weight has been taken and the patient presents within 2 h of ingestion. These measures are of little value in patients who present more than 2 h after ingestion. 2 While waiting for measurement of the plasma paracetamol concentration, oral methionine (not NAC) may be given to patients who present within 4 h of ingestion of a large amount of paracetamol if activated charcoal has not been given. 3 Take blood for urgent estimation of the plasma paracetamol as soon as 4 h or more have elapsed since ingestion. 4 Assess whether the patient is at special risk of severe liver damage (see GENERAL 5 and 6 above). 5 The risk of the patient developing severe liver damage should then be assessed by considering the plasma paracetamol concentration related to the time from ingestion using treatment line A (graph) if the patient is not at special risk or line B if the patient is. 6 overdose is controversial. All should have their INR, plasma creatinine concentrations, and arterial pH (or hydrogen ion concentration) determined and we recommend that they be discussed with a poisons information centre or a specialist liver or poisons unit.
MANAGEMENT OF CHILDREN
The advice in these guidelines also applies to the management of children. The following guidelines apply to the administration of NAC to children:
Volumes for NAC infusion-paediatric 20 kg and over:
(1) 150 mg/kg IV infusion over 15 min in 100 ml 5% glucose. (2) Then 50 mg/kg IV infusion in 250 ml 5% glucose over 4 h. (3) Then 100 mg/kg IV infusion in 500 ml 5% glucose over 16 h.
Under 20 kg: Volumes for infusion of the above doses are the responsibility of the prescriber, and should be based on the daily maintenance requirements of the child by weight. 
